Pancreatic cancer cell- and cancer-associated fibroblast-derived exosomes in disease progression, metastasis, and therapy
Authors:
Open Access
- 2 July 2024
- journal article
- review article
- Published by Springer Nature in Discover Oncology
- Vol. 15 (1) , 1-10
Abstract
Exosomes play a crucial role in the progression and spread of pancreatic cancer, serving not only as promoters of tumor growth and organ-specific metastasis but also as promising biomarkers and targets for treatment. These nano vesicles enhance intercellular communication by transferring bioactive molecules, such as proteins and RNAs, between cells. This process significantly affects cancer cell dynamics, including their proliferation, migration, and invasion, while also contributing to drug resistance. Our review focuses on the crucial interactions between cancer cells and fibroblasts mediated by exosomes within the pancreatic cancer microenvironment. We delve into how exosomes from both cancer-associated fibroblasts and the cancer cells themselves drive tumor progression through various mechanisms, such as epithelial-mesenchymal transition and facilitating metastasis to specific organs like the lungs and liver. The potential of leveraging exosomes for therapeutic interventions is also explored, highlighting the importance of understanding their role in cell communication as a step forward in developing more effective pancreatic cancer treatments.Keywords
Funding Information
- China Scholarship Council (202208080050)
- Martin-Luther-Universität Halle-Wittenberg
This publication has 67 references indexed in Scilit:
- Cancer‐associated fibroblast‐secreted miR‐421 promotes pancreatic cancer by regulating the SIRT3/H3K9Ac/HIF‐1α axisThe Kaohsiung Journal of Medical Sciences, 2022
- Bone marrow mesenchymal stem cells-derived exosomes for penetrating and targeted chemotherapy of pancreatic cancerActa Pharmaceutica Sinica B, 2020
- Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasisCancer Letters, 2020
- Gemcitabine loaded autologous exosomes for effective and safe chemotherapy of pancreatic cancerActa Biomaterialia, 2020
- Exosomal miRNA‐1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancerCancer Medicine, 2019
- Exosomes derived from pancreatic cancer cells induce activation and profibrogenic activities in pancreatic stellate cellsBiochemical and Biophysical Research Communications, 2018
- Revisiting epithelial‐mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemnessMolecular Oncology, 2017
- Impact of lysosome status on extracellular vesicle content and releaseAgeing Research Reviews, 2016
- Exosome cargo reflects TGF-β1-mediated epithelial-to-mesenchymal transition (EMT) status in A549 human lung adenocarcinoma cellsBiochemical and Biophysical Research Communications, 2016
- Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survivalInternational Journal of Cancer, 2009